San Francisco Neuroscience →
President & CEO, Indiana Biosciences Research Institute
Serial Entrepreneur and Investor
Founder, The Haul Company
CEO and Fund Manager, Renaissance Venture Capital Fund
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Founder and Managing Director of DEV
VP of Research & Policy, Ewing Marion Kauffman Foundation
Partner at New Enterprise Associates
November 19, 2019 · San Francisco
Sigilon Therapeutics uses a capsule it developed to safely deliver engineered cells, which can deliver targeted protein therapeutics. Image courtesy of Sigilon.
Sponsored · Whitepaper
How to accelerate your life sciences business with every agreement
What the most successful life sciences fundraising pitch decks all have in common
From Our Editors · Special Report
Key indicators & expert insight from industry leaders
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.